MST Access has initiated coverage of Race Oncology with a current $4.88 per share valuation.

The full report can be downloaded below.

Related posts:

Race appoints Dr Daniel Tillett Chief Scientific Officer Prominent biotech investor leads investment in Race Race appoints leading haematologist to support Bisantrene